🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/02/2002 | 57,54 | 57,91 | 57,01 | 57,81 | +0,60% | 1,56% | 5.761.275 |
| 12/02/2002 | 56,60 | 57,78 | 56,50 | 57,46 | +1,30% | 2,26% | 6.067.815 |
| 11/02/2002 | 56,45 | 56,85 | 55,96 | 56,73 | +0,51% | 1,57% | 4.280.346 |
| 08/02/2002 | 55,40 | 57,24 | 55,06 | 56,44 | +1,41% | 3,94% | 5.242.725 |
| 07/02/2002 | 55,84 | 56,38 | 55,40 | 55,66 | -0,49% | 1,76% | 4.635.409 |
| 06/02/2002 | 56,30 | 56,58 | 55,73 | 55,94 | -1,31% | 1,53% | 4.238.007 |
| 05/02/2002 | 55,34 | 56,89 | 55,27 | 56,68 | +1,64% | 2,93% | 4.716.419 |
| 04/02/2002 | 56,71 | 56,72 | 55,46 | 55,76 | -1,67% | 2,22% | 4.371.627 |
| 01/02/2002 | 56,32 | 56,87 | 56,23 | 56,71 | +0,42% | 1,14% | 4.906.422 |
| 31/01/2002 | 55,87 | 56,56 | 55,59 | 56,47 | +0,58% | 1,74% | 6.833.274 |
| 30/01/2002 | 55,32 | 56,77 | 55,08 | 56,15 | +2,29% | 3,07% | 10.328.564 |
| 29/01/2002 | 55,58 | 56,15 | 54,48 | 54,89 | +0,91% | 3,02% | 12.117.919 |
| 28/01/2002 | 54,67 | 54,68 | 54,11 | 54,39 | +0,07% | 1,03% | 5.198.709 |
| 25/01/2002 | 54,56 | 54,68 | 54,20 | 54,35 | -1,15% | 0,87% | 6.826.043 |
| 24/01/2002 | 55,35 | 55,52 | 54,69 | 54,98 | -1,08% | 1,50% | 7.385.151 |
| 23/01/2002 | 56,75 | 57,14 | 55,58 | 55,58 | -1,75% | 2,74% | 7.475.908 |
| 22/01/2002 | 55,76 | 56,77 | 55,76 | 56,57 | +2,22% | 1,80% | 5.512.480 |
| 18/01/2002 | 55,92 | 56,20 | 54,89 | 55,34 | -1,02% | 2,35% | 5.840.714 |
| 17/01/2002 | 55,51 | 56,20 | 55,42 | 55,92 | +0,64% | 1,41% | 4.393.950 |
| 16/01/2002 | 56,15 | 56,56 | 55,52 | 55,56 | -0,72% | 1,87% | 4.209.397 |
| 15/01/2002 | 56,77 | 57,11 | 55,39 | 55,96 | -0,34% | 3,03% | 8.557.025 |
| 14/01/2002 | 56,39 | 57,13 | 56,15 | 56,15 | -0,22% | 1,73% | 5.304.138 |
| 11/01/2002 | 56,87 | 57,11 | 55,85 | 56,28 | +0,02% | 2,21% | 5.967.207 |
| 10/01/2002 | 55,73 | 56,29 | 55,60 | 56,27 | +0,25% | 1,23% | 5.461.862 |
| 09/01/2002 | 56,04 | 56,92 | 55,92 | 56,13 | +0,15% | 1,79% | 6.867.544 |
| 08/01/2002 | 55,44 | 56,04 | 55,40 | 56,04 | +1,08% | 1,15% | 7.456.520 |
| 07/01/2002 | 55,76 | 55,96 | 55,37 | 55,44 | -1,34% | 1,06% | 5.809.378 |
| 04/01/2002 | 55,87 | 56,19 | 55,30 | 56,19 | -0,24% | 1,61% | 6.844.383 |
| 03/01/2002 | 57,02 | 57,02 | 55,73 | 56,33 | -1,22% | 2,28% | 8.374.987 |
| 02/01/2002 | 56,44 | 57,11 | 55,44 | 57,02 | +1,63% | 2,96% | 7.540.465 |